Search results
Oppenheimer maintains bullish rating on Broadcom following management meeting By Investing.com
Investing.com· 31 minutes agoOppenheimer maintains bullish rating on Broadcom following management meeting
Barnes Group shares target raised by Oppenheimer on valuation outlook By Investing.com
Investing.com· 4 hours agoOn Friday, Oppenheimer adjusted its outlook on Barnes Group (NYSE:B) shares, a global provider of...
Robert Downey Jr. Says ‘The Sympathizer’ Star Hoa Xuande Pulled ‘All the Same Moves’ as Cillian...
The Wrap via Yahoo News· 3 days ago"All I saw was this guy sacrifice and sacrifice," the HBO star and EP says of his similar costars...
Oppenheimer cuts Spruce Biosciences shares target, cites updated revenue forecasts By Investing.com
Investing.com· 1 day agoOn Thursday, Oppenheimer adjusted its price target for Spruce Biosciences, Inc. (NASDAQ:SPRB)...
AGCO (NYSE:AGCO) Price Target Cut to $133.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 10 hours agoAGCO (NYSE:AGCO – Get Free Report) had its target price decreased by investment analysts at ...
Oppenheimer Lowers Cellectis (NASDAQ:CLLS) Price Target to $10.00
ETF DAILY NEWS· 10 hours agoCellectis (NASDAQ:CLLS – Get Free Report) had its target price dropped by Oppenheimer from $11.00 to $10.00 in a note issued to investors on Wednesday, Benzinga reports. The ...
Theater Owners Chief on Box Office Downturn, Alamo Drafthouse Sale and Bringing Audiences Back to...
Variety via Yahoo News· 1 hour agoIt’s been a tough time for the movie business. The 2023 actors and writers strikes brought...
In spite of recent selling, insiders still control 44% of Oppenheimer Holdings Inc. (NYSE:OPY)
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Insiders appear to have a vested interest in Oppenheimer Holdings' growth, as seen by...
Emily Blunt Circling Steven Spielberg’s Next Summer Tentpole At Amblin & Universal – The Dish
Deadline via Yahoo News· 19 hours agoEXCLUSIVE: After earning an Oscar nomination for her work in Christopher Nolan’s Oppenheimer, Emily...
Aramark (NYSE:ARMK) PT Raised to $39.00 at Oppenheimer
ETF DAILY NEWS· 12 hours agoAramark (NYSE:ARMK – Get Free Report) had its price objective upped by equities researchers at Oppenheimer from $36.00 to $39.00 in a research report issued on Wednesday, ...